“albumedix” Archives

Entry Author Date Location
Eleven Bio Buys Viventia, Rebrands as Cancer Drug Developer 09/21/16 Boston
Eleven Bio’s Eye Disease Drug Set For $22.5M Milestone from Roche 07/08/16 Boston
Eleven Bio, Still Breathing, Sells Eye Drug to Roche 06/13/16 Boston
Novozymes Spins Off Pharma Unit as Separate Blood Protein Company 01/19/16 Raleigh Durham
Page 1 of 1